On 29 September 2026 in Washington, D.C., IFPMA delivered a statement on the strategy for strengthening health emergency and ...
Governments around the world are confronting increasingly common challenges: how to drive economic growth, address demographic changes and productivity pressures, and how to strengthen national ...
In this op-ed, authors argue that Europe will be among the first to confront the central question of how to ensure that ...
On 25 September 2026 in New York City, IFPMA Director General David Reddy participated in an official panel at the UN ...
This op-ed argues that Japan, as the world's first super-aging society, can set a global standard for how prevention protects ...
On 1 October 2026 in Washington, D.C., IFPMA delivered a statement on the policy on the application of data science in public ...
In this op-ed, authors argue that Europe will be among the first to confront the central question of how to ensure that ...
Pharmaceutical innovation – the core of our industry’s work – relies on pushing the limits of scientific knowledge to advance new medicines and vaccines for the benefit of people everywhere.
Anna Puchot supports strategic communications across IFPMA’s priority policy areas. Her work includes the development of policy communications, stakeholder engagement, member-facing content, and ...
The 77th World Health Assembly (WHA) marks the deadline for the conclusion of a pandemic agreement and amended International Health Regulations (2005) that seek to make the world better prepared for ...
IFPMA worked with Clarivate to study how different countries and regions approach the regulation of post-approval changes (PACs) in biotherapeutic products. The research compared PACs guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results